De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Quipt Home Medical Beheer
Beheer criteriumcontroles 2/4
De CEO Quipt Home Medical's is Greg Crawford, benoemd in Dec2017, heeft een ambtstermijn van 6.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 1.88M, bestaande uit 31.8% salaris en 68.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 4.03% van de aandelen van het bedrijf, ter waarde CA$ 6.82M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 6.7 jaar en 6.8 jaar.
Belangrijke informatie
Greg Crawford
Algemeen directeur
US$1.9m
Totale compensatie
| Percentage CEO-salaris | 31.8% |
| Dienstverband CEO | 6.8yrs |
| Eigendom CEO | 4.0% |
| Management gemiddelde ambtstermijn | 6.7yrs |
| Gemiddelde ambtstermijn bestuur | 6.8yrs |
Recente managementupdates
Recent updates
Earnings Release: Here's Why Analysts Cut Their Quipt Home Medical Corp. (TSE:QIPT) Price Target To CA$10.95
Aug 17
Is Quipt Home Medical (TSE:QIPT) A Risky Investment?
Aug 16Quipt Home Medical Corp.'s (TSE:QIPT) 26% Price Boost Is Out Of Tune With Revenues
Jul 26Returns At Quipt Home Medical (TSE:QIPT) Are On The Way Up
Jul 17Investors Aren't Entirely Convinced By Quipt Home Medical Corp.'s (TSE:QIPT) Revenues
Apr 19Quipt Home Medical Corp. (TSE:QIPT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
Feb 17What Is Quipt Home Medical Corp.'s (TSE:QIPT) Share Price Doing?
Sep 25Calculating The Fair Value Of Quipt Home Medical Corp. (TSE:QIPT)
Sep 01We Think Quipt Home Medical's (CVE:QIPT) Robust Earnings Are Conservative
Feb 21Earnings Update: Quipt Home Medical Corp. (CVE:QIPT) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Aug 18Health Check: How Prudently Does Quipt Home Medical (CVE:QIPT) Use Debt?
Jul 13When Should You Buy Quipt Home Medical Corp. (CVE:QIPT)?
Jun 08Quipt Home Medical Corp. (CVE:QIPT) Shares Could Be 43% Below Their Intrinsic Value Estimate
Jun 02Does Protech Home Medical (CVE:PTQ) Have A Healthy Balance Sheet?
May 07Protech Home Medical Corp. (CVE:PTQ) Could Be Less Than A Year Away From Profitability
Mar 29Can You Imagine How Elated Protech Home Medical's (CVE:PTQ) Shareholders Feel About Its 331% Share Price Gain?
Feb 22Calculating The Fair Value Of Protech Home Medical Corp. (CVE:PTQ)
Jan 18Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$5m |
| Mar 31 2024 | n/a | n/a | -US$4m |
| Dec 31 2023 | n/a | n/a | -US$4m |
| Sep 30 2023 | US$2m | US$597k | -US$3m |
| Jun 30 2023 | n/a | n/a | US$310k |
| Mar 31 2023 | n/a | n/a | US$2m |
| Dec 31 2022 | n/a | n/a | US$7m |
| Sep 30 2022 | US$843k | US$558k | US$5m |
| Jun 30 2022 | n/a | n/a | US$2m |
| Mar 31 2022 | n/a | n/a | US$8m |
| Dec 31 2021 | n/a | n/a | -US$10m |
| Sep 30 2021 | US$4m | US$513k | -US$6m |
| Jun 30 2021 | n/a | n/a | -US$5m |
| Mar 31 2021 | n/a | n/a | -US$14m |
| Dec 31 2020 | n/a | n/a | US$1m |
| Sep 30 2020 | US$440k | US$425k | -US$4m |
| Jun 30 2020 | n/a | n/a | US$428k |
| Mar 31 2020 | n/a | n/a | -US$6m |
| Dec 31 2019 | n/a | n/a | -US$11m |
| Sep 30 2019 | US$652k | US$425k | -US$7m |
| Jun 30 2019 | n/a | n/a | -US$27m |
| Mar 31 2019 | n/a | n/a | -US$18m |
| Dec 31 2018 | n/a | n/a | -US$20m |
| Sep 30 2018 | US$1m | US$418k | -US$7m |
Compensatie versus markt: De totale vergoeding ($USD 1.88M ) Greg } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Canadian markt ($USD 177.89K ).
Compensatie versus inkomsten: De vergoeding van Greg is gestegen terwijl het bedrijf verliesgevend is.
CEO
Greg Crawford
6.8yrs
Tenure
US$1,878,047
Compensatie
Mr. Gregory J. Crawford also known as Greg, serves as Director at DMEscripts LLC. He has been President, Chief Executive Officer and Chairman of Quipt Home Medical Corp. (formerly known as Protech Home Med...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman | 6.8yrs | US$1.88m | 4.03% $ 6.4m | |
| Chief Financial Officer | 6.7yrs | US$1.71m | geen gegevens | |
| Executive Vice President of Operations | 3yrs | geen gegevens | geen gegevens | |
| Chief Strategy Officer & Investor Relations | no data | US$308.24k | geen gegevens | |
| VP of Corporate Development & VP of Investor Relations | no data | geen gegevens | geen gegevens | |
| Vice President of Information Technology | no data | geen gegevens | geen gegevens | |
| Executive Vice President of Finance | 5.1yrs | geen gegevens | geen gegevens | |
| Corporate Secretary | 12.8yrs | geen gegevens | geen gegevens |
6.7yrs
Gemiddelde duur
50yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van QIPT is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.7 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman | 6.8yrs | US$1.88m | 4.03% $ 6.4m | |
| Independent Non Executive Director | 6.8yrs | US$1.10m | 0.47% $ 746.4k | |
| Member of the Board of Advisors | 11yrs | geen gegevens | geen gegevens | |
| Member of the Board of Advisors | 11yrs | geen gegevens | geen gegevens | |
| Independent Non-Executive Director | 3.8yrs | US$476.95k | 0.12% $ 185.5k | |
| Independent Director | 2.7yrs | US$660.88k | 0.098% $ 157.2k |
6.8yrs
Gemiddelde duur
Ervaren bestuur: De raad van bestuur van QIPT wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.8 jaar).